Clinical Trial Update: PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis [NA]

View source ↗

Summary

A completed clinical trial evaluating PREMAPROB probiotics to prevent necrotizing enterocolitis in premature infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• PREMAPROB Probiotic (probiotic)

Snippet

Sponsor: José Antonio Hurtado Suazo | Conditions: Premature Infants, Necrotizing Enterocolitis | NA | Status: COMPLETED